Research / SYM / Fundamental state Inspectable configuration
State dimensions Filing 0001837240-24-000228 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.63% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
5.36% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
47.40% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
30.45% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
7.68% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-16.50% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
11.81% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
7.14% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Jun 25, 2022 0/4 normalized Level 3 Sep 24, 2022 0/7 normalized Level 3 Dec 24, 2022 0/7 normalized Level 3 Mar 25, 2023 0/7 normalized Level 3 Jun 24, 2023 0/8 normalized Level 3 Sep 30, 2023 0/8 normalized Level 3 Dec 30, 2023 0/8 normalized Level 3 Mar 30, 2024 0/8 normalized Level 3 Jun 29, 2024 4/8 normalized Level 3 Dec 30, 2023 0/8 normalized Amended as filed Mar 30, 2024 0/8 normalized Amended as filed Jun 29, 2024 4/8 normalized Amended as filed Sep 28, 2024 7/8 normalized Level 3 Dec 28, 2024 7/8 normalized Level 3 Mar 29, 2025 6/7 normalized Level 3 Jun 28, 2025 7/7 normalized Level 3 Sep 27, 2025 7/7 normalized Level 3 Dec 27, 2025 7/7 normalized Level 3 Mar 28, 2026 7/7 normalized Level 3 Jun 27, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 0.60%
Current 0.63%
Delta 0.03% Cash Generation Increased
Previous -8.38%
Current 5.36%
Delta 13.73% Growth Decreased
Previous 74.47%
Current 47.40%
Delta -27.07% Inventory Pressure Decreased
Previous 38.25%
Current 30.45%
Delta -7.80% Margin Decreased
Previous 17.80%
Current 7.68%
Delta -10.11% Profitability Decreased
Previous -6.97%
Current -16.50%
Delta -9.53% R And D Intensity Increased
Previous 11.71%
Current 11.81%
Delta 0.10% Sbc Intensity Decreased
Previous 8.19%
Current 7.14%
Delta -1.05% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.